{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:14:22Z","timestamp":1785575662071,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2011004"],"award-info":[{"award-number":["GNT2011004"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["2021\/CDF1120"],"award-info":[{"award-number":["2021\/CDF1120"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK128612"],"award-info":[{"award-number":["DK128612"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008457","name":"University of Virginia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008457","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bbadis.2023.166908","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T15:37:39Z","timestamp":1696261059000},"page":"166908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Head-to-head comparison of BAM15, semaglutide, rosiglitazone, NEN, and calorie restriction on metabolic physiology in female db\/db mice"],"prefix":"10.1016","volume":"1870","author":[{"given":"Sing-Young","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Olzomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances L.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Salamoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Larance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Philp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Webster L.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cantley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle L.","family":"Hoehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2023.166908_bb0005","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1590\/1413-81232018238.10222016","article-title":"Drug utilization and factors associated with polypharmacy in individuals with diabetes mellitus in Minas Gerais, Brazil","volume":"23","author":"Silva","year":"2018","journal-title":"Cien Saude Colet."},{"key":"10.1016\/j.bbadis.2023.166908_bb0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s13340-021-00495-5","article-title":"Evaluation of multiple drug use in patients with type 2 diabetes mellitus","volume":"12","author":"\u0130nci","year":"2021","journal-title":"Diabetol. Int."},{"key":"10.1016\/j.bbadis.2023.166908_bb0015","series-title":"Ozempic\u00ae (Semaglutide) Approved in the US","author":"Nordisk","year":"2017"},{"key":"10.1016\/j.bbadis.2023.166908_bb0020","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2023.166908_bb0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11154-021-09699-1","article-title":"Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes","volume":"23","author":"Mahapatra","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bbadis.2023.166908_bb0030","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1021\/acs.jmedchem.7b01182","article-title":"Small molecule mitochondrial uncouplers and their therapeutic potential","volume":"61","author":"Childress","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2023.166908_bb0035","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2013.10.004","article-title":"Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler","volume":"18","author":"Perry","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2023.166908_bb0040","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.aaa0672","article-title":"Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats","volume":"347","author":"Perry","year":"2015","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbadis.2023.166908_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay0284","article-title":"Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates","volume":"11","author":"Goedeke","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2023.166908_bb0050","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/nm.3699","article-title":"Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice","volume":"20","author":"Tao","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2023.166908_bb0055","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/s41467-019-09911-6","article-title":"Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler","volume":"10","author":"Kanemoto","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2023.166908_bb0060","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.2337\/db19-0589","article-title":"Mitochondrial uncoupling coordinated with PDH activation safely ameliorates hyperglycemia via promoting glucose oxidation","volume":"68","author":"Jiang","year":"2019","journal-title":"Diabetes."},{"key":"10.1016\/j.bbadis.2023.166908_bb0065","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s41467-020-16298-2","article-title":"Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice","volume":"11","author":"Alexopoulos","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2023.166908_bb0070","article-title":"Targeting negative energy balance with calorie restriction and mitochondrial uncoupling in db\/db mice","volume":"101684","author":"Chen","year":"2023","journal-title":"Molec. Metab."},{"key":"10.1016\/j.bbadis.2023.166908_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2042-6410-3-13","article-title":"Sex differences in human adipose tissues \u2013 the biology of pear shape","volume":"3","author":"Karastergiou","year":"2012","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.bbadis.2023.166908_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.828522","article-title":"Sex and species differences in the development of diet-induced obesity and metabolic disturbances in rodents","volume":"9","author":"Maric","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.bbadis.2023.166908_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.physbeh.2017.08.016","article-title":"Gender differences in glucose homeostasis and diabetes","volume":"187","author":"Mauvais-Jarvis","year":"2018","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbadis.2023.166908_bb0090","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.1039\/C9RA10593J","article-title":"Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites","volume":"10","author":"Wang","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbadis.2023.166908_bb0095","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.2337\/db16-1213","article-title":"Pair feeding, but not insulin, Phloridzin, or rosiglitazone treatment, curtails markers of \u03b2-cell dedifferentiation in db\/db mice","volume":"66","author":"Ishida","year":"2017","journal-title":"Diabetes."},{"key":"10.1016\/j.bbadis.2023.166908_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8503754","article-title":"db\/db mice exhibit features of human Type 2 diabetes that are not present in weight-matched C57BL\/6J mice fed a western diet","volume":"2017","author":"Burke","year":"2017","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bbadis.2023.166908_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082813","article-title":"Characterisation of age-dependent beta cell dynamics in the male db\/db mice","volume":"8","author":"Dalboge","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2023.166908_bb0110","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13615","article-title":"Bias in the reporting of sex and age in biomedical research on mouse models","volume":"5","author":"Fl\u00f3rez-Vargas","year":"2016","journal-title":"eLife."},{"key":"10.1016\/j.bbadis.2023.166908_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062833","article-title":"Rosiglitazone treatment of type 2 diabetic db\/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion","volume":"8","author":"Chodavarapu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2023.166908_bb0120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.13005\/bpj\/1376","article-title":"Comparison of rosiglitazone and metformin in genetically obese and diabetic db\/db mice and streptozotocin-induced diabetic rat models","volume":"11","author":"Patil","year":"2018","journal-title":"Biomed. Pharmacol. J."},{"key":"10.1016\/j.bbadis.2023.166908_bb0125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166908_bb0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2613.2011.00793.x","article-title":"Pathology of the liver in obese and diabetic ob\/ob and db\/db mice fed a standard or high-calorie diet","volume":"92","author":"Trak-Smayra","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2023.166908_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258942","article-title":"Gastric bypass prevents diabetes in genetically modified mice and chemically induced diabetic mice","volume":"16","author":"Zhu","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2023.166908_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbadis.2023.166908_bb0145","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/oby.23374","article-title":"Beyond appetite regulation: targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss","volume":"30","author":"Christoffersen","year":"2022","journal-title":"Obesity."},{"key":"10.1016\/j.bbadis.2023.166908_bb0150","series-title":"FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. USA: FDA","author":"FDA","year":"2021"},{"key":"10.1016\/j.bbadis.2023.166908_bb0155","series-title":"Updates About Wegovy","author":"Nordisk","year":"2022"},{"key":"10.1016\/j.bbadis.2023.166908_bb0160","series-title":"Joint Statement: Prioritisation of Semaglutide (Ozempic) Supply for People With Type 2 Diabetes During Shortage","author":"Therapeutic Goods Administration","year":"2022"},{"key":"10.1016\/j.bbadis.2023.166908_bb0165","doi-asserted-by":"crossref","first-page":"721135","DOI":"10.3389\/fendo.2021.721135","article-title":"GLP-1 receptor agonists: beyond their pancreatic effects","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbadis.2023.166908_bb0170","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S2213-8587(21)00174-1","article-title":"Efficacy and safety of once-weekly semaglutide 2.0 mg versus 1.0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial","volume":"9","author":"Fr\u00edas","year":"2021","journal-title":"Lancet Diab. Endocrinol."},{"key":"10.1016\/j.bbadis.2023.166908_bb0175","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166908_bb0180","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s001250100031","article-title":"Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients","volume":"44","author":"Miyazaki","year":"2001","journal-title":"Diabetologia."},{"key":"10.1016\/j.bbadis.2023.166908_bb0185","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2023.166908_bb0190","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial","volume":"368","author":"The DREAM Trial Investigators","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2023.166908_bb0195","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMp1309610","article-title":"The cardiovascular safety of diabetes drugs \u2014 insights from the rosiglitazone experience","volume":"369","author":"Hiatt","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2023.166908_bb0200","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012088","article-title":"BAM15-mediated mitochondrial uncoupling protects against obesity and improves glycemic control","volume":"12","author":"Axelrod","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbadis.2023.166908_bb0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0306-3623(96)00149-8","article-title":"The mechanisms of action of antiprotozoal and anthelmintic drugs in man","volume":"28","author":"Frayha","year":"1997","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.bbadis.2023.166908_bb0210","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41598-018-37376-y","article-title":"Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes","volume":"9","author":"Hinder","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923002740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923002740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T05:15:17Z","timestamp":1735708517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923002740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0925443923002740"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166908","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Head-to-head comparison of BAM15, semaglutide, rosiglitazone, NEN, and calorie restriction on metabolic physiology in female db\/db mice","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166908"}}